MNF Group Limited (MNF) News

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave...

Form 8-K - Current report

NanoVibronix Issues Letter to Stockholders

NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and...

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award

Distribution Partner, Delta Medical, Awarded a Five-Year Federal Supply Schedule Contract for PainShield by Department of Veterans Affairs...

NanoVibronix Issues Letter to Stockholders

NanoVibronix, Inc., (NASDAQ: NAOV)(“NanoVibronix”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface...

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

Efforts Focused on Adding Therapeutic Functionality and Reducing Costs NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix” or the “Company”), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material